Grimes & Company Inc. Boosts Position in The Beauty Health Company $SKIN

Grimes & Company Inc. grew its holdings in shares of The Beauty Health Company (NASDAQ:SKIN) by 85.2% in the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 406,987 shares of the company’s stock after purchasing an additional 187,226 shares during the period. Grimes & Company Inc.’s holdings in Beauty Health were worth $777,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. Simplicity Wealth LLC acquired a new position in shares of Beauty Health during the 2nd quarter valued at $49,000. Newman Dignan & Sheerar Inc. raised its position in Beauty Health by 28.1% in the second quarter. Newman Dignan & Sheerar Inc. now owns 91,144 shares of the company’s stock valued at $174,000 after purchasing an additional 20,000 shares during the period. Kapitalo Investimentos Ltda acquired a new position in shares of Beauty Health during the second quarter worth about $60,000. Goldman Sachs Group Inc. boosted its position in shares of Beauty Health by 5.0% in the first quarter. Goldman Sachs Group Inc. now owns 665,706 shares of the company’s stock worth $892,000 after buying an additional 31,880 shares during the period. Finally, SCS Capital Management LLC acquired a new stake in shares of Beauty Health in the first quarter valued at about $67,000. Hedge funds and other institutional investors own 93.26% of the company’s stock.

Analyst Ratings Changes

Several research firms recently commented on SKIN. Weiss Ratings reissued a “sell (e+)” rating on shares of Beauty Health in a research report on Saturday, September 27th. Cowen reissued a “hold” rating on shares of Beauty Health in a research report on Monday, September 22nd. TD Cowen raised their price target on shares of Beauty Health from $2.00 to $2.50 and gave the company a “hold” rating in a report on Monday, September 22nd. Roth Capital initiated coverage on shares of Beauty Health in a report on Friday, September 19th. They issued a “buy” rating and a $3.50 price objective on the stock. Finally, Stifel Nicolaus upped their price objective on shares of Beauty Health from $3.00 to $4.00 and gave the company a “hold” rating in a research report on Friday, August 1st. One analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $2.81.

Beauty Health Stock Performance

Shares of SKIN stock opened at $1.67 on Tuesday. The stock has a market capitalization of $211.79 million, a price-to-earnings ratio of -5.96 and a beta of 1.21. The Beauty Health Company has a one year low of $0.78 and a one year high of $2.69. The company’s 50-day simple moving average is $2.05 and its 200-day simple moving average is $1.70. The company has a debt-to-equity ratio of 4.91, a quick ratio of 4.15 and a current ratio of 5.15.

Beauty Health (NASDAQ:SKIN) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.03 earnings per share for the quarter, beating the consensus estimate of ($0.06) by $0.09. Beauty Health had a negative return on equity of 32.82% and a negative net margin of 6.13%.The firm had revenue of $78.20 million during the quarter, compared to analyst estimates of $74.67 million. Beauty Health has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Equities analysts anticipate that The Beauty Health Company will post -0.25 earnings per share for the current fiscal year.

Beauty Health Profile

The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health.